OBJECTIVE -To compare patient outcomes 1 year before and 1 year after enrollment in a comprehensive diabetes lower-extremity amputation prevention program.
D
iabetes is the leading cause of nontraumatic lower-extremity amputation (LEA) in the U.S. In Louisiana, based on Centers for Disease Control and Prevention national estimates, there are ϳ2,575 diabetes-related lower-limb amputations yearly (1) . Minor foot injury, ulceration, and faulty healing are the most common pathways to LEA (2) . Loss of sensation and high foot stress are the primary causes of foot ulcers (3) (4) (5) . Within 5 years of developing a plantar ulcer, the cumulative recurrence rate of ulceration is 70%, and the amputation rate is 12% (6) .
The LEA rate in African-Americans is more than twice that of non-Hispanic whites (7, 8) . The U.S. Department of Health and Human Services' Healthy People 2010 report calls for a 40% overall reduction in LEAs, including a special population target goal of reducing the rate of amputations in African-Americans from 10.2 to 6.1 per 1,000 by the year 2010 (1) .
The Louisiana State University Health Sciences Center (LSUHSC), which is responsible for providing health care to a low-income predominantly African-American population of individuals in Louisiana, established a Comprehensive Diabetes Lower Extremity Amputation Prevention Program (CD-LEAP) in March 1998. The state hospital definition of low income is an individual income of less than $17,000 per year. The purpose of the program is to reduce the prevalence of diabetes-related foot problems and the rate of LEAs by improving access and reducing disparity in foot care services to the population served. CD-LEAP is a multidisciplinary program based on the Bureau of Primary Health Care National LEAP Initiative and treatment techniques developed at the National Hansen's Disease Center in Carville, Louisiana. The program focuses on the prevention of foot injuries and the management of early foot lesions.
Foot ulcerations and amputations resulting from foot injuries associated with loss of protective sensation are considered preventable. A few studies have supported the effectiveness of a basic LEAP program in reducing diabetes-related foot problems and LEAs (9) (10) (11) . In a longitudinal study of Chippewa Indians, Rith-Najarian et al. (12) showed that a basic LEAP program accompanied by the staged management of foot problems was effective in reducing LEAs by 50% compared with standard care. The
Effectiveness of Comprehensive LEAP
effectiveness of a LEAP program in reducing diabetes-related foot problems and LEAs in a predominantly low-income AfricanAmerican population has not been studied.
The LSUHSC Diabetes Foot Program (DFP) accepts all patients with a diagnosis of diabetes or related disorders with neuropathic foot complications referred from local and regional physicians within the Louisiana State Hospital system. Local community referrals are accepted on an availability basis.
All patients receive an initial diabetes foot screen to identify the individual' s relative risk for foot injury (Tables 1 and 2 ) (13) . Patients at low risk (risks 0 and 1) are provided foot care education, assistance in the selection of proper fitting and designed footwear, and routine follow-up to manage simple problems. Patients at high risk (risks 2 and 3) are provided custom-molded orthoses and prescription footwear to reduce foot pressure and are followed at a more frequent interval. Molded orthoses and footwear modifications are fabricated on site by a certified pedorthist. Patients with foot injuries (ulcerations and Charcot osteoarthropathies) are provided the highest priority of care. Wound debridement, moist dressings, contact casts, and other specially designed custom off-loading appliances are used to promote healing (14) . Surgical intervention is provided via consultation through the state hospital system. The program is designed to provide long-term follow-up for all patients at risk.
This study compared foot-related outcomes for diabetic patients after 1-year enrollment in the LSUHSC CD-LEAP Program with Standard Care outcomes 1 year prior to enrollment. Standard care in the state hospital system and in community programs consisted of noncoordinated treatment of foot problems provided in primary care clinics, in emergency rooms, and in wound care, surgical, and podiatry clinics. In contrast, CD-LEAP is case management of individuals with high-risk feet. CD-LEAP provides staged educational services, management of complex nail and callus problems, availability and ready accessibility for early management of injuries, and onsite fabrication of orthotics, footwear, casts, and other devices designed to off-load pressure.
RESEARCH DESIGN AND METHODS -Outcome data were obtained using a structured interview administered by a registered nurse blinded to the study. Interview questions asked by the nurse directly corresponded to the variables measured (i.e., how many times were you hospitalized for a foot-related problem in the last year?). Recordings were made of the number of days with an open foot wound (ulcer days), the number of times hospitalized for a foot problem (hospitalizations), the number of days spent in the hospital for a foot problem (hospital days), the number of visits to the emergency room for a foot problem (emergency room visits), the number of times an antibiotic was prescribed for a foot problem (antibiotic prescriptions), the number of all foot operations (foot oper- ations), the number of LEAs (LEAs), and the number of missed workdays for a foot problem (missed workdays). Outcome data was obtained on all diabetic patients at the initial visit and after 1 year of follow-up. Data were analyzed on the first 300 patients enrolled in the program. Interview data were collected over an 18-month period. An additional measure, ulcer incidence, was the number of individual patients developing new ulcers. This variable was only used to evaluate treatment response among groups in the follow-up year.
RESULTS -Of the first 300 patients treated at the LSUHSC DFP, 197 had a diagnosis of diabetes and completed initial and 1-year follow-up outcome interviews, 24 were nondiabetic, 18 died, and 61 were lost to follow-up. None of the patient deaths were foot related. Patients lost to follow-up were slightly younger than those followed (50.1 ± 12.9 and 55.7 ± 10.4 years, respectively). There was no difference in sex, ethnicity, or income status between the 2 groups. Analysis of data using paired t tests showed a large reduction in foot-related ulcer days, hospitalizations, hospital days, emergency room visits, antibiotic prescriptions, foot operations, LEAs, and missed workdays after 1 year of treatment at the LSUHSC-DFP compared with the 1-year period before enrollment (Table 3) . Individuals with ulceration on initial screening were not used for determining ulceration rates in the follow-up year. Individuals in the highest risk groups, as determined on the initial foot screen, had the highest risk of foot ulceration and amputation at the 1-year follow-up. There was no difference in the incidence of foot ulceration between low-income and non-low-income patients (Table 4) . Ulcer incidence was lower in African-American patients than in non-African-American patients (Table 5) in the follow-up year.
CONCLUSIONS -Research supports the high morbidity and progressive nature of diabetes-related foot problems. In this single cohort study, however, there was a large improvement in foot outcomes in a high-risk population of diabetic patients after a 1-year enrollment in the CD-LEAP program. The improvement was attributed to the consistent application of appropriate preventive care, treatment, and careful follow-up. Early detection and effective treatment of foot ulcers is considered the best method of interrupting the pathway to LEAs. Patients in the LSUHSC Diabetes Foot Program were taught to self-examine their feet daily, were fit with appropriate footwear, and were offered a responsive treatment program when lesions developed. Before enrollment in this program, the majority of patients did not have access to comprehensive preventive foot care. The generalization of these results, however, is limited by the lack of a comparison group in this study and the fact that the long-term effectiveness of a CD-LEAP program has not been demonstrated. The risk category criteria used on initial screening were found to predict foot ulceration and LEA (Table 6 ). This result agrees with the findings of a previous study (15) and validates the use of this risk category scale by diabetes foot prevention programs.
Initial LEA rates (0.096/person-year) in the LSUHSC cohort were 9 times the national rate of amputation (0.011/personyear) (1) for people with diabetes, whereas in the follow-up year, the amputation rate was reduced to ϳ2 times the national rate. The high amputation rate in the LSUHSC cohort is not surprising for a diabetes foot program managing a predominantly highrisk low-income minority population. In this study, the fall in LEA rates (79%) after the implementation of CD-LEAP is comparable to the reduction in LEAs (50%) found by Rith-Najarian et al. (15) after the implementation of LEAP plus the staged management of foot problems.
The LSUHSC Diabetes Foot Program provides care to patients regardless of income or insurance status. The ability of the program to provide parity of and access to care in low-income and minority patients was assessed in this study. The rate of foot ulcerations was found to be lower in African-American patients compared with non-African-American patients and was the same in low-income patients compared with non-low-income patients in the follow-up year.
In conclusion, we state the following: 1) This single cohort outcome study showed a large reduction in foot-related ulcer days, hospitalizations, hospital days, emergency room visits, antibiotic prescriptions, foot operations, LEAs, and missed workdays after the first year of comprehensive preventive foot care. 2) There was no disparity in ulcer incidence between 
